Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- S.2030
S.2030: Advancing Targeted Therapies for Rare Diseases Act of 2016
About This Bill
- This bill was introduced in the 114th Congress
- This bill is primarily about health
- Introduced Sept. 15, 2015
- Latest Major Action April 5, 2016
Bill Sponsor
Bill Cosponsors
5 (1 Democrat, 4 Republicans)
Bill Summary
Advancing Targeted Therapies for Rare Diseases Act of 2016 (Sec. 2) This bill amends the Federal Food, Drug, and Cosmetic Act to permit the Food and Drug Administration to allow the sponsor of a new drug or biological product for the treatment of a rare, serious condition to rely upon information submitted for an approved medication that uses the same technology. For a sponsor to be eligible to rely upon submitted information: (1) the sponsor...
(Source: Library of Congress)
What Lawmakers Are Saying About This Bill
Bill Actions
| Date | Description |
|---|---|
| April 5, 2016 |
Placed on Senate Legislative Calendar under General Orders. Calendar No. 416.
|
| April 5, 2016 |
Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.
|
| Feb. 9, 2016 |
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
|
| Sept. 15, 2015 |
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
|
| Sept. 15, 2015 |
Introduced in the Senate by Michael Bennet (D-Colo.) |